Thalidomide for malignant melanoma [5]

New England Journal of Medicine

Volumn 345, Issue 16, 2001, Pages 1214-1215

  Kudva, Ganesh C ^a   Collins, Brian T ^a   Dunphy II, Frank R ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BCG VACCINE; PROTEIN S 100; THALIDOMIDE;

ADULT; ASPIRATION BIOPSY; CASE REPORT; CONSTIPATION; DIAGNOSTIC IMAGING; HEMIPLEGIA; HUMAN; IMMUNOTHERAPY; LETTER; MALE; MELANOMA; PRIORITY JOURNAL; REMISSION; STROKE; TREATMENT FAILURE;

HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS; THALIDOMIDE;

EID: 0035909660     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200110183451617     Document Type: Letter

References (3)

1. Continuous low dose thalidomide: A advanced melanoma, renal cell, ovarian and breast cancer
2. Thalidomide in solid tumors: The London experience
3. New approaches in the treatment of metastatic melanoma: Thalidomide and temozolamide